Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

264 ARTÍCULOS , VIENDO DEL 241 AL 255

The metabotropic glutamate receptor 1, GRM1: evaluation as a candidate gene for inherited forms of cerebellar ataxia

Rossi PI, Vaccari CM, Terracciano A, Doria-Lamba L, Facchinetti S, Priolo M, Ayuso C, De Jorge L, Gimelli S, Santorelli FM, Ravazzolo R, Puliti A.

J Neurol. 2010 Apr;257(4):598-602. doi: 10.1007/s00415-009-5380-3. Epub 2009 Nov 19.

Movement disorders in neuro-metabolic diseases

Gouider-Khouja N, Kraoua I, Benrhouma H, Fraj N, Rouissi A.

Eur J Paediatr Neurol. 2010 Jul;14(4):304-7. doi: 10.1016/j.ejpn.2009.11.005. Epub 2009 Dec 16.

Dementia in Fragile X-associated Tremor/Ataxia Syndrome

Nitrini R, Gonçalves MRR, Capelli LP, Barbosa ER, Porto CS, Amaro E, Otto PA, Vianna-Morgante AM.

Dement Neuropsychol. 2010 Jan-Mar;4(1):79-83. doi: 10.1590/S1980-57642010DN40100014.

Fragile X-associated tremor/ataxia syndrome (FXTAS) with myoclonus

Poston KL, McGovern RA, Goldman JS, Caccappolo E, Mazzoni P.

Mov Disord. 2010 Mar 15;25(4):514-6. doi: 10.1002/mds.22929.

Amiodarone-induced liver cirrhosis and parkinsonism: a case report

Ishida S, Sugino M, Hosokawa T, Sato T, Furutama D, Fukuda A, Kimura F, Kuwabara H, Shibayama Y, Hanafusa T.

Clin Neuropathol. 2010 Mar-Apr;29(2):84-8. doi: 10.5414/npp29084.

Loss of beta-III spectrin leads to Purkinje cell dysfunction recapitulating the behavior and neuropathology of spinocerebellar ataxia type 5 in humans

Perkins EM, Clarkson YL, Sabatier N, Longhurst DM, Millward CP, Jack J, Toraiwa J, Watanabe M, Rothstein JD, Lyndon AR, Wyllie DJ, Dutia MB, Jackson M.

J Neurosci. 2010 Apr 7;30(14):4857-67. doi: 10.1523/JNEUROSCI.6065-09.2010.

RNA-mediated neurodegeneration in repeat expansion disorders

Todd PK, Paulson HL.

Ann Neurol. 2010 Mar;67(3):291-300. doi: 10.1002/ana.21948.

Coexisting huntingtin and SCA8 repeat expansion: case report of a severe complex neurodegenerative syndrome

Bereznai B, Lovas G, Pentelenyi K, Rudas G, Molnar MJ.

J Neurol Sci. 2010 Jun 15;293(1-2):116-8. doi: 10.1016/j.jns.2010.03.006. Epub 2010 Apr 18.

Fluconazole-induced intoxication with phenytoin in a patient with ultra-high activity of CYP2C9

Helldén A, Bergman U, Engström Hellgren K, Masquelier M, Nilsson Remahl I, Odar-Cederlöf I, Ramsjö M, Bertilsson L.

Eur J Clin Pharmacol. 2010 Aug;66(8):791-5. doi: 10.1007/s00228-010-0820-7. Epub 2010 Apr 20.

Advances in understanding the molecular basis of FXTAS

Garcia-Arocena D, Hagerman PJ.

Hum Mol Genet. 2010 Apr 15;19(R1):R83-9. doi: 10.1093/hmg/ddq166. Epub 2010 Apr 29.

Early onset of neurological symptoms in fragile X premutation carriers exposed to neurotoxins

Paul R, Pessah IN, Gane L, Ono M, Hagerman PJ, Brunberg JA, Tassone F, Bourgeois JA, Adams PE, Nguyen DV, Hagerman R.

Neurotoxicology. 2010 Aug;31(4):399-402. doi: 10.1016/j.neuro.2010.04.002. Epub 2010 May 11.

A Japanese case of fragile-X-associated tremor/ataxia syndrome (FXTAS)

Ishii K, Hosaka A, Adachi K, Nanba E, Tamaoka A.

Intern Med. 2010;49(12):1205-8. doi: 10.2169/internalmedicine.49.3258. Epub 2010 Jun 15.

Carisoprodol withdrawal after internet purchase

Eleid MF, Krahn LE, Agrwal N, Goodman BP.

Neurologist. 2010 Jul;16(4):262-4. doi: 10.1097/NRL.0b013e3181aa917e.

Tremor-ataxia with central hypomyelination (TACH) leukodystrophy maps to chromosome 10q22.3-10q23.31

Bernard G, Thiffault I, Tetreault M, Putorti ML, Bouchard I, Sylvain M, Melançon S, Laframboise R, Langevin P, Bouchard JP, Vanasse M, Vanderver A, Sébire G, Brais B.

Neurogenetics. 2010 Oct;11(4):457-64. doi: 10.1007/s10048-010-0251-8. Epub 2010 Jul 17.

Fragile X: leading the way for targeted treatments in autism

Wang LW, Berry-Kravis E, Hagerman RJ.

Neurotherapeutics. 2010 Jul;7(3):264-74. doi: 10.1016/j.nurt.2010.05.005.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias